BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 21451785)

  • 1. Advances in ovarian cancer screening: health and medicine for women: a multidisciplinary, evidence-based review of mid-life health concerns.
    Ahmad S
    Yale J Biol Med; 2011 Mar; 84(1):47-9. PubMed ID: 21451785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A close call: the role of screening mammography in the fight against breast cancer: health and medicine for women: a multidisciplinary, evidence-based review of mid-life health concerns.
    Sadeghpour M
    Yale J Biol Med; 2011 Mar; 84(1):43-5. PubMed ID: 21451784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An update on hormone replacement therapy: health and medicine for women: a multidisciplinary, evidence-based review of mid-life health concerns.
    Shook LL
    Yale J Biol Med; 2011 Mar; 84(1):39-42. PubMed ID: 21451783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Screening for ovarian cancer in BRCA1/BRCA2 mutations carriers].
    Synowiec A; Wcisło G; Bodnar L; Gasowska-Bodnar A; Szczylik C
    Ginekol Pol; 2014 May; 85(5):377-81. PubMed ID: 25011220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress report on ovarian cancer screening. Scientists are making headway in detecting ovarian cancer at an earlier stage.
    Harv Womens Health Watch; 2010 Apr; 17(8):1-3. PubMed ID: 20506601
    [No Abstract]   [Full Text] [Related]  

  • 6. [Polish Gynecological Society's recommendations regarding ovarian cancer].
    Spaczyński M; Bidziński M; Basta A; Dańska-Bidzińska A; Breborowicz GH; Emerich J; Grabiec M; Kedzia W; Kornafel J; Kotarski J; Markowska J; Nowak-Markwitz E; Michalska M; Niecewicz R; Olejek A; Poznański J; Radowicki S; Rechberger T; Roszak A; Rzepka-Górska I; Skret A; Suzin J; Szymański W; Urbański K;
    Ginekol Pol; 2006 Jul; 77(7):495-501. PubMed ID: 17076198
    [No Abstract]   [Full Text] [Related]  

  • 7. A systematic review of the bimanual examination as a test for ovarian cancer.
    Ebell MH; Culp M; Lastinger K; Dasigi T
    Am J Prev Med; 2015 Mar; 48(3):350-6. PubMed ID: 25595604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the need for faculty development in women's health among internal medicine and family practice teaching faculty. The Women's Health Education Working Group (WHEWG).
    Kwolek DS; Witzke D; Sloan DA
    J Womens Health Gend Based Med; 1999 Nov; 8(9):1195-201. PubMed ID: 10595333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethical concerns relating to the detection and treatment of ovarian cancer.
    Jansen LA
    Gynecol Oncol; 2002 Jan; 84(1):1-3. PubMed ID: 11748967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early detection of ovarian tumors using ultrasound.
    Pavlik EJ; van Nagell JR
    Womens Health (Lond); 2013 Jan; 9(1):39-55; quiz 56-7. PubMed ID: 23241154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vignette-based study of ovarian cancer screening: do U.S. physicians report adhering to evidence-based recommendations?
    Baldwin LM; Trivers KF; Matthews B; Andrilla CH; Miller JW; Berry DL; Lishner DM; Goff BA
    Ann Intern Med; 2012 Feb; 156(3):182-94. PubMed ID: 22312138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovarian cancer awareness.
    Aust Nurs Midwifery J; 2014 Feb; 21(7):11. PubMed ID: 24678559
    [No Abstract]   [Full Text] [Related]  

  • 13. Screening for ovarian cancer in the general population.
    Gentry-Maharaj A; Menon U
    Best Pract Res Clin Obstet Gynaecol; 2012 Apr; 26(2):243-56. PubMed ID: 22182415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. When evidence says no: gynaecologists' reasons for (not) recommending ineffective ovarian cancer screening.
    Wegwarth O; Pashayan N
    BMJ Qual Saf; 2020 Jun; 29(6):521-524. PubMed ID: 31704891
    [No Abstract]   [Full Text] [Related]  

  • 15. [Program for early detection of ovarian cancer for women as prophylaxis provided at a municipal hospital].
    Cnota W; Sodowski K; Olesiak-Andryszczak M; Pilch-Kowalczyk M
    Wiad Lek; 2004; 57 Suppl 1():43-7. PubMed ID: 15884203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Test for ovarian, endometrial cancers. Could cells taken from a Pap test offer the first-ever early screening method?
    Harv Womens Health Watch; 2013 Apr; 20(8):5. PubMed ID: 23885374
    [No Abstract]   [Full Text] [Related]  

  • 17. Improving women's health: advances, failures and cancer genome prospects.
    Katsios C; Zoras O; Roukos DH
    Womens Health (Lond); 2010 Nov; 6(6):769-72. PubMed ID: 21118033
    [No Abstract]   [Full Text] [Related]  

  • 18. Diagnostic and Prognostic Biomarkers in ovarian cancer and the potential roles of cancer stem cells - An updated review.
    Muinao T; Deka Boruah HP; Pal M
    Exp Cell Res; 2018 Jan; 362(1):1-10. PubMed ID: 29079264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer Screening in Women.
    Vogell A; Evans ML
    Obstet Gynecol Clin North Am; 2019 Sep; 46(3):485-499. PubMed ID: 31378290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ovarian cancer - screening and diagnosis].
    Marić J; Klarić M; Bačić B
    Acta Med Croatica; 2014 Jun; 68(3):273-81. PubMed ID: 26016218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.